DETAIL

DETAIL INFORMATION

Anhui Fengyuan Pharmaceutical Co., Ltd. Wuwei Pharmaceutical Factory

Published:

2018-08-07

Source:

Author:

The predecessor of Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in the 1970s. After half a century of development, it has become a large pharmaceutical enterprise integrating pharmaceutical research and development, production and sales. In 2000, the company was listed on the Shenzhen Stock Exchange (stock code: 000153), and has been listed as one of the top 100 pharmaceutical companies in China since 2007. Enterprise, 2015 China Innovative Pharmaceutical Enterprise. The company's total assets are 2.274 billion yuan and more than 4,700 employees. The company has 15 subsidiaries including pharmaceutical production, pharmaceutical marketing, large pharmacy chain and 1 nationally recognized enterprise technology center.

The predecessor of Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in the 1970s. After half a century of development, it has now become a large pharmaceutical enterprise integrating pharmaceutical research and development, production and sales. In 2000, the company was listed on the Shenzhen Stock Exchange (stock code: 000153), and has been listed in China's top 100 pharmaceutical industry since 2007. It is a pilot enterprise for system implementation and a Chinese innovative pharmaceutical enterprise in 2015. The company's total assets are 2.274 billion yuan and more than 4,700 employees. The company has 15 subsidiaries including pharmaceutical production, pharmaceutical marketing, large pharmacy chain and 1 nationally recognized enterprise technology center.

In 2020, the company's main income is 3.3 billion yuan, and the tax payment is 227 million yuan; in 2021, the company's main income is about 3.5 billion yuan, and the tax payment is about 220 million yuan. Among them, Wuwei Pharmaceutical will achieve sales revenue of 438 million yuan in 2020 and pay taxes of 44.4 million yuan; in 2021, it will achieve sales revenue of 350 million yuan and pay taxes of about 26 million yuan.

Wuwei Pharmaceutical Factory mainly produces electrolyte infusions, amino acid series injections, fat emulsion series injections, fructose injections, polygelatin injections, lomefloxacin, metronidazole, mannitol and other 61 varieties of multi-specification infusions preparation. Among them, the national sales volume of fat emulsion series injection and fructose injection ranks first.

In 2012, Wuwei Pharmaceutical Factory responded to the call of Wuwei County Party Committee and County Government to "delist and enter the park", and started construction in Wuwei County Economic Development Zone in April 2013. The first phase of the project invested 268 million yuan and resumed the original annual production. The capacity of infusion is 200 million bottles/bag, and the relocation of the whole plant was successfully completed in January 2017. Along with the construction of the new plant, focus on strengthening the adjustment of product structure, increasing the development of therapeutic and nutritional varieties, the current development idea is to create "specialized, refined and new" varieties, and two varieties of fat emulsion series are being clinically and developed; In order to solve the difficulty of hemodialysis for uremia patients, a new peritoneal dialysis solution project of 220 million yuan has been completed. It is expected that the product will be launched in 2023, and will achieve an additional sales income of 200 million yuan and a tax of 20 million yuan; the third is to optimize the company's resources It is planned to build Wuwei Pharmaceutical Factory into a preparation production base of Fengyuan Pharmaceutical in the future.

Fengyuan Pharmaceutical has always adhered to the tenet of "reproducing green life and caring for human health", and has made unremitting efforts to achieve national interests, corporate interests and employee interests.

Back

Anhui Fengyuan Pharmaceutical Co., Ltd. Huaihai Pharmaceutical Factory

Relative news

Warm congratulations to Fengyuan Pharmaceutical on the successful convening of the 2013 annual work summary and commendation conference

On January 25, 2014, Fengyuan Pharmaceutical held the 2013 annual work summary and commendation meeting in the multi-functional hall on the sixth floor of the headquarters. The headquarters executives, managers and employees of various functional departments, the leadership team of subsidiaries and advanced individuals participated in the meeting. Meeting. The meeting first summarized the work in 2013 and looked forward to 2014. At the same time, advanced individuals and groups with outstanding performance were commended. After the meeting, the company arranged a wonderful "2014 Welcome Party" and a rich dinner.

2022-06-30

Revisiting the history, cherishing the present, and looking forward to the future---remember the July 1 Party Member Activity Conference of Fengyuan Pharmaceutical Party Branch

At 15:00 on July 1, 2015, the party committee of Fengyuan Pharmaceutical held a party member activity meeting for the 94th anniversary of the founding of the party in the company's No. 1 conference room. The conference was presided over by Ru Tianle, Secretary of the Party Committee of the company. The event was divided into two main agendas: the swearing-in ceremony of new party members and the training of party history class. All party members stood up and sang "The Internationale" to kick off the event. The first item of the agenda, first of all, Ru Tianle, secretary of the party committee, read out the list of prospective party members and led three new party members to take the oath of joining the party facing the national flag. The old party member representative Xiao Guosong made a speech, mainly reporting to the participating party members his experience in work and life as an old party member, advocating

2022-06-30

Practical training in corporate strategic thinking and strategy formulation

From April 12th to 13th, 2015, the company organized the training of "Enterprise Strategic Thinking and Strategy Formulation Practice", and the middle and senior managers of the company and the senior managers of subsidiaries participated in the training. The following are training pictures:

2022-06-30

Warmly welcome the leaders of Wuhu City to visit Wuwei Pharmaceutical Factory for inspection and guidance

On March 3, 2015, Wuhu Municipal Party Committee Secretary Gao Dengbang, Mayor Pan Zhaohui, Deputy Mayor Lin Xuwen and some other members of the four major groups, the principals of various counties and districts and other government leaders visited Fengyuan Pharmaceutical Wuwei Pharmaceutical Factory Fudu New Plant for inspection Guidance, the company's general manager Gao Ji, Wuwei pharmaceutical factory director Hu Baowen accompanied the whole process. First of all, the company's general manager, on behalf of all the company's employees, extended a warm welcome to all the leaders, and made a detailed report on Anhui Fengyuan Pharmaceutical Co., Ltd., the fundraising project of Wuwei Pharmaceutical Factory, and the product planning of Wuwei Pharmaceutical Factory in the next five years. While providing the physical samples, he introduced the Wuwei Pharmaceutical Factory to the inspection leaders.

2022-06-30

图片名称

86-0551-64846100

图片名称

127841476@qq.com

大兴

CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd  Powered by：www.300.cn  SEO

京ICP备10002622号-38